Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hyungcheon Kim"'
Publikováno v:
Journal of Korean Society for Atmospheric Environment. 38:802-822
Autor:
Yunseo Park, Changhan Bae, Seo-yeon Park, Hyungcheon Kim, Hyang-kyeong Lee, Su-ah Choi, Seung-joo Song, Chul Gyu Yoo, Kyoung-Bin Lee, Young-Min Kim, Hyeon-ji Lee, Seong-woo Choi, Taekyu Kim, Jeong-pil Jang
Publikováno v:
Asian Journal of Atmospheric Environment, Vol 15, Iss 4, Pp 1-28 (2021)
According to the 2017 National Air Pollutant Emissions Inventory (NEI), air pollutant emissions in the Republic of Korea comprised 817,420 metric tons (hereafter tons) of CO, 1,189,800 tons of NOx, 315,530 tons of SOx, 592,582 tons of TSP, 218,476 to
Publikováno v:
Journal of Korean Society for Atmospheric Environment. 37:338-354
Autor:
Chul Gyu Yoo, Sang-ho Shin, Eugene Cho, Hyungcheon Kim, Eun-hyouck Lim, Seong-woo Choi, Hyang-kyeong Lee, Taekyu Kim, Hyungah Jin, Jihyun Han, Kyoung-Bin Lee, Young-min Kim
Publikováno v:
Asian Journal of Atmospheric Environment, Vol 14, Iss 4, Pp 422-445 (2020)
In 2016, air pollutant emissions in the Republic of Korea were 795,044 metric tons (hereafter tons) of CO, 1,248,309 tons of NOx, 358,951 tons of SOx , 611,539 tons of TSP, 233,085 tons of PM10, 100,247 tons of PM2.5, 16,401 tons of BC, 1,024,029 ton
Publikováno v:
Journal of Korean Society for Atmospheric Environment. 36:785-805
Autor:
Sang Hyub Lee, Y. S. Cho, H. S. Seo, Woo Jin Lew, Hyungcheon Kim, E. J. Lee, Y. M. Lee, Jae-Joon Yim, Hyun Kyung Lee, Tae Sun Shim
Publikováno v:
Epidemiology and Infection. 140:1028-1035
SUMMARYWe screened tuberculosis (TB) contacts as an outbreak investigation with tuberculin skin test (TST) and interferon-gamma release assay (IGRA). We evaluated adverse events and TB incidence in all persons screened after rifampicin (RFP) prophyla
Autor:
Min Jae Kim, Hyung-Chun Kim, Chul Gyu Yoo, Y. S. Shim, Sang Min Lee, Youngwhan Kim, Seung Sik Hwang, Jae-Joon Yim, Sungkoo Han, Hyungcheon Kim
Publikováno v:
The European respiratory journal. 33(3)
Recently, resistance to additional first-line and injectable drugs was reported to be an independent risk factor for adverse outcomes in multidrug-resistant (MDR) tuberculosis (TB) patients. The aim of the present study was to confirm these observati